Ajanta Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Ajanta Pharma Ltd. on BSE

Load latest

Ajanta Pharma Ltd.

01 Jul 2022

2541.90

-0.26%

SAST

AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 01, 2022 for Ravi P Agrawal, trustee Ravi Agrawal Trust

pdf

Ajanta Pharma Ltd.

30 Jun 2022

2541.90

-0.26%

SAST

AJANTA PHARMA LTD. - 532331 - Closure of Trading Window

BSE India

Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and 'Ajanta's Code of Conduct for Insiders', the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (as defined in the Code) from close of business hours of 30th June 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended 30th June 2022. Kindly take the above information on your record.

pdf

Ajanta Pharma Ltd.

28 Jun 2022

2541.90

-0.26%

Corp. Note

AJANTA PHARMA LTD. - 532331 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Information on loss of shares

pdf

Ajanta Pharma Ltd.

27 Jun 2022

2541.90

-0.26%

SAST

AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 27, 2022 for Aayush Agrawal, trustee Aayush Agrawal Trust

pdf

Ajanta Pharma Ltd.

24 Jun 2022

2541.90

-0.26%

Company Update

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

The Company has allotted 4,27,08,385 Bonus Equity Shares of Rs. 2/- each as fully-paid up Bonus Equity Shares, in the proportion of 1:2, to the eligible Members whose names appeared on the register of Members/list of beneficial owners as on 23rd June 2022, i.e. record date fixed for this purpose. Consequently, the paid-up Equity Share Capital of the Company stands increased from Rs. 17,08,33,540 divided into 8,54,16,770 Equity Shares of Rs. 2/- each to Rs. 25,62,50,310 divided into 12,81,25,155 Equity Shares of Rs. 2/- each. As part of the aforesaid allotment 14,758 Bonus Equity Shares representing fractional entitlement(s) of eligible Members have been consolidated and allotted to a separate account opened for this purpose. Such equity shares would be sold at the prevailing market rate as soon as possible and the net sale proceeds after adjusting the cost and expenses in respect thereof, would be distributed amongst the members as per their respective fractional entitlements.

pdf

Ajanta Pharma Ltd.

24 Jun 2022

2541.90

-0.26%

SAST

AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 23, 2022 for Aayush Agrawal, trustee Aayush Agrawal Trust

pdf

Ajanta Pharma Ltd.

21 Jun 2022

2541.90

-0.26%

AGM

AJANTA PHARMA LTD. - 532331 - Intimation Of Annual General Meeting

BSE India

Forty-Third (43rd) Annual General Meeting ('AGM') of the Company will be held on Thursday, 4th August 2022 at 11.00 a.m. through Video-conference or Other Audio-Visual Means.

pdf

Ajanta Pharma Ltd.

13 Jun 2022

2541.90

-0.26%

AGM

AJANTA PHARMA LTD. - 532331 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Ajanta Pharma Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Ajanta Pharma Ltd.

13 Jun 2022

2541.90

-0.26%

Corp. Action

AJANTA PHARMA LTD. - 532331 - Intimation Of Record Date Pursuant To Regulation 42 Of The …

BSE India

The Executive Committee of the Board of Directors has pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 fixed Thursday, 23rd June 2022 as the record date for the said corporate action. Kindly take the above intimation on your record and display the same on website of the Exchange.

pdf

Ajanta Pharma Ltd.

13 Jun 2022

2541.90

-0.26%

AGM

AJANTA PHARMA LTD. - 532331 - Declaration Of Voting Results Of Postal Ballot Under Regulation 44 …

BSE India

Pursuant to Regulation 44(3) of the Listing Regulations, please find enclosed herewith voting results and the Scrutinizer''s Report thereon dated 13th June 2022. Kindly take the above on your records.

pdf

Is Ajanta Pharma Ltd. worth buying?

189 Votes:

Buy 77.25%

Sell 15.87%

Hold 6.88%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf